Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00490646
Status:
COMPLETED
Last Update Posted:
2016-03-10
First Post:
2007-06-21
Brief Title:
A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced andor Metastatic Breast Cancer
Sponsor:
R-Pharm
Organization:
R-Pharm
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Breast Cancer |
Keywords:
| Name | View |
|---|---|
| Locally advanced andor metastatic breast cancer | View |